206 related articles for article (PubMed ID: 34857764)
1. Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker.
Lechtenberg BC; Gehring MP; Light TP; Horne CR; Matsumoto MW; Hristova K; Pasquale EB
Nat Commun; 2021 Dec; 12(1):7047. PubMed ID: 34857764
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains.
Gehring MP; Pasquale EB
Cell Signal; 2020 Sep; 73():109668. PubMed ID: 32413552
[TBL] [Abstract][Full Text] [Related]
3. The SAM domain inhibits EphA2 interactions in the plasma membrane.
Singh DR; Ahmed F; Paul MD; Gedam M; Pasquale EB; Hristova K
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):31-38. PubMed ID: 27776928
[TBL] [Abstract][Full Text] [Related]
4. PIP
Stefanski KM; Russell CM; Westerfield JM; Lamichhane R; Barrera FN
J Biol Chem; 2021; 296():100149. PubMed ID: 33277361
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor.
Mercurio FA; Marasco D; Pirone L; Pedone EM; Pellecchia M; Leone M
Biochemistry; 2012 Mar; 51(10):2136-45. PubMed ID: 22332920
[TBL] [Abstract][Full Text] [Related]
6. Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains.
Borthakur S; Lee H; Kim S; Wang BC; Buck M
J Biol Chem; 2014 Jul; 289(28):19694-703. PubMed ID: 24825902
[TBL] [Abstract][Full Text] [Related]
7. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase.
Sharonov GV; Bocharov EV; Kolosov PM; Astapova MV; Arseniev AS; Feofanov AV
J Biol Chem; 2014 May; 289(21):14955-64. PubMed ID: 24733396
[TBL] [Abstract][Full Text] [Related]
8. Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain?
Mercurio FA; Costantini S; Di Natale C; Pirone L; Guariniello S; Scognamiglio PL; Marasco D; Pedone EM; Leone M
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1095-1104. PubMed ID: 28602916
[TBL] [Abstract][Full Text] [Related]
9. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
10. EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling.
Singh DR; Ahmed F; King C; Gupta N; Salotto M; Pasquale EB; Hristova K
J Biol Chem; 2015 Nov; 290(45):27271-27279. PubMed ID: 26363067
[TBL] [Abstract][Full Text] [Related]
11. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
[TBL] [Abstract][Full Text] [Related]
12. Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues.
Mercurio FA; Marasco D; Di Natale C; Pirone L; Costantini S; Pedone EM; Leone M
Chembiochem; 2016 Nov; 17(22):2179-2188. PubMed ID: 27763725
[TBL] [Abstract][Full Text] [Related]
13. A role of the SAM domain in EphA2 receptor activation.
Shi X; Hapiak V; Zheng J; Muller-Greven J; Bowman D; Lingerak R; Buck M; Wang BC; Smith AW
Sci Rep; 2017 Mar; 7():45084. PubMed ID: 28338017
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis for Auto-Inhibition of the NDR1 Kinase Domain by an Atypically Long Activation Segment.
Xiong S; Lorenzen K; Couzens AL; Templeton CM; Rajendran D; Mao DYL; Juang YC; Chiovitti D; Kurinov I; Guettler S; Gingras AC; Sicheri F
Structure; 2018 Aug; 26(8):1101-1115.e6. PubMed ID: 29983373
[TBL] [Abstract][Full Text] [Related]
15. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
Chen J; Schaller S; Jardetzky TS; Longnecker R
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
[TBL] [Abstract][Full Text] [Related]
17. Structures of an Eph receptor tyrosine kinase and its potential activation mechanism.
Wei Q; Liu J; Wang N; Zhang X; Jin J; Chin-Sang I; Zheng J; Jia Z
Acta Crystallogr D Biol Crystallogr; 2014 Dec; 70(Pt 12):3135-43. PubMed ID: 25478832
[TBL] [Abstract][Full Text] [Related]
18. Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions.
Wang Y; Shang Y; Li J; Chen W; Li G; Wan J; Liu W; Zhang M
Elife; 2018 May; 7():. PubMed ID: 29749928
[TBL] [Abstract][Full Text] [Related]
19. The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
Mercurio FA; Leone M
Curr Med Chem; 2016; 23(42):4718-4734. PubMed ID: 27804871
[TBL] [Abstract][Full Text] [Related]
20. Sam domain-based stapled peptides: Structural analysis and interaction studies with the Sam domains from the EphA2 receptor and the lipid phosphatase Ship2.
Mercurio FA; Pirone L; Di Natale C; Marasco D; Pedone EM; Leone M
Bioorg Chem; 2018 Oct; 80():602-610. PubMed ID: 30036816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
